Physician profile
Jack Griffeth
NPI 1548262561
$3,512.36
in general payments reported to CMS, 2019-2025
19 companies · $905 in 2025
The $905 reported for 2025 was more than what 82% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $108 · 2021: $284 · 2022: $244 · 2023: $1,046 · 2024: $631 · 2025: $905.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,032 · Honoraria: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,032.04 |
| Honoraria | $550.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Theragenics Corporation | $878.07 | 2019-2025 | |
| Bard Peripheral Vascular, INC. | $550.00 | 2023 | |
| Bioprotect Medical, INC. | $498.30 | 2024-2025 | Bioprotect Balloon Implant System |
| Siemens Medical Solutions USA, INC. | $339.84 | 2023-2025 | Bravos Afterloader System |
| Boston Scientific Corporation | $266.08 | 2021-2024 | Spaceoar System, Spaceoar Vue System - 10ml |
| Isoray, INC | $221.10 | 2022-2023 | Brachytherapy Source |
| Elekta, INC. | $168.18 | 2023 | Flexitron Hdr |
| Sumitomo Pharma America, INC. | $107.51 | 2023-2024 | Orgovyx |
| Blue Earth Diagnostics | $99.67 | 2021 | |
| Brainlab, INC. | $95.01 | 2019-2020 | |
| Myovant Sciences INC. | $83.29 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $47.29 | 2021-2022 | |
| Teleflex LLC | $42.24 | 2024 | |
| Reflexion Medical, INC. | $26.94 | 2022 | |
| Fortovia Therapeutics, INC. | $22.92 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $17.04 | 2020 | |
| Genzyme Corporation | $16.68 | 2019 | |
| Novocure INC. | $16.53 | 2022 | |
| Exelixis INC. | $15.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Griffeth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.